Advertisement
Screener

VivoSim Labs, Inc. (VIVS) Revenues

2.8 / 5 stars · 68/120 Roast Me

VivoSim Labs, Inc. Revenues

VivoSim Labs, Inc. (VIVS) reported Revenues of $1.10 million for the 3-month period ending 2018-03-31, per its 10-K filed 2018-05-31.

Discontinued › Income Statement › Revenue

us-gaap:Revenues · last filed 2018-05-31

  • VivoSim Labs, Inc. revenues for the quarter ending 2018-03-31 was $1.10M, a 36.08% increase year-over-year.
  • VivoSim Labs, Inc. revenues for the quarter ending 2017-12-31 was $1.15M, a 0.17% increase year-over-year.
  • VivoSim Labs, Inc. revenues for the quarter ending 2017-09-30 was $1.35M, a 1.53% decline year-over-year.
  • VivoSim Labs, Inc. revenues for the quarter ending 2017-06-30 was $990.00K, a 11.11% increase year-over-year.
  • VivoSim Labs, Inc. revenues for fiscal 2018 was $4.60M, a 8.82% increase from fiscal 2017.
  • VivoSim Labs, Inc. revenues for fiscal 2017 was $4.23M, a 185.23% increase from fiscal 2016.
  • VivoSim Labs, Inc. revenues for fiscal 2016 was $1.48M, a 159.72% increase from fiscal 2015.
  • VivoSim Labs, Inc. revenues for fiscal 2015 was $571.00K, a 50.66% increase from fiscal 2014.
Period endRevenues 3 monthRevenues 3 month as first filedRevenues 6 monthRevenues 9 monthRevenues 12 monthRevenues 21 monthRevenues 24 monthRevenues 59 monthRevenues 62 monthRevenues 65 monthRevenues 68 monthRevenues 71 monthRevenues 74 monthRevenues 77 monthRevenues 80 monthRevenues 83 month
2018-03-31$1.10M
10-K · filed 2018-05-31
$2.26M
derived: sum of 2 quarters · filed 2018-05-31
$3.61M
derived: sum of 3 quarters · filed 2018-05-31
$4.60M
10-K · filed 2018-05-31
2017-12-31$1.15M
10-K · filed 2018-05-31
$2.51M
derived: sum of 2 quarters · filed 2018-05-31
$3.50M
10-Q · filed 2018-02-08
$4.31M
derived: sum of 4 quarters · filed 2018-05-31
2017-09-30$1.35M
10-K · filed 2018-05-31
$2.35M
10-Q · filed 2017-11-09
$3.16M
derived: sum of 3 quarters · filed 2018-05-31
$4.31M
derived: sum of 4 quarters · filed 2018-05-31
2017-06-30$990.00K
10-K · filed 2018-05-31
$1.80M
derived: sum of 2 quarters · filed 2018-05-31
$2.95M
derived: sum of 3 quarters · filed 2018-05-31
$4.33M
derived: sum of 4 quarters · filed 2018-05-31
2017-03-31$812.00K
10-K · filed 2018-05-31
$1.96M
derived: sum of 2 quarters · filed 2018-05-31
$3.34M
derived: sum of 3 quarters · filed 2018-05-31
$4.23M
10-K · filed 2018-05-31
2016-12-31$1.15M
10-K · filed 2018-05-31
$2.53M
derived: sum of 2 quarters · filed 2018-05-31
$3.42M
10-Q · filed 2018-02-08
$3.97M
derived: sum of 4 quarters · filed 2018-05-31
2016-09-30$1.38M
10-K · filed 2018-05-31
$2.27M
10-Q · filed 2017-11-09
$2.81M
derived: sum of 3 quarters · filed 2018-05-31
$3.14M
derived: sum of 4 quarters · filed 2018-05-31
2016-06-30$891.00K
10-K · filed 2018-05-31
$1.44M
derived: sum of 2 quarters · filed 2018-05-31
$1.77M
derived: sum of 3 quarters · filed 2018-05-31
$2.07M
derived: sum of 4 quarters · filed 2018-05-31
2016-03-31$548.00K
10-K · filed 2017-06-07
$876.00K
derived: sum of 2 quarters · filed 2017-06-07
$1.18M
derived: sum of 3 quarters · filed 2017-06-07
$1.48M
10-K · filed 2018-05-31
2015-12-31$328.00K
10-K · filed 2017-06-07
$629.00K
derived: sum of 2 quarters · filed 2017-06-07
$935.00K
10-Q · filed 2017-02-09
$1.20M
derived: sum of 4 quarters · filed 2017-06-07
2015-09-30$301.00K
10-K · filed 2017-06-07
$607.00K
10-Q · filed 2016-11-03
$874.00K
derived: sum of 3 quarters · filed 2017-06-07
$1.03M
derived: sum of 4 quarters · filed 2017-06-07
2015-06-30$306.00K
10-K · filed 2017-06-07
$573.00K
derived: sum of 2 quarters · filed 2017-06-07
$728.00K
derived: sum of 3 quarters · filed 2017-06-07
$778.00K
derived: sum of 4 quarters · filed 2017-06-07
2015-03-31$267.00K
10-K · filed 2016-06-09
$422.00K
derived: sum of 2 quarters · filed 2016-06-09
$472.00K
derived: sum of 3 quarters · filed 2016-06-09
$571.00K
10-K · filed 2017-06-07
2014-12-31$155.00K
10-K · filed 2016-06-09
$205.00K
derived: sum of 2 quarters · filed 2016-06-09
$304.00K
10-Q · filed 2016-02-08
$419.00K
derived: sum of 4 quarters · filed 2016-06-09
2014-09-30$50.00K
10-K · filed 2016-06-09
$149.00K
10-Q · filed 2015-11-09
$264.00K
derived: sum of 3 quarters · filed 2016-06-09
$399.00K
derived: sum of 4 quarters · filed 2016-06-09
2014-06-30$99.00K
10-K · filed 2016-06-09
$214.00K
derived: sum of 2 quarters · filed 2016-06-09
$349.00K
derived: sum of 3 quarters · filed 2016-06-09
$372.00K
derived: sum of 4 quarters · filed 2016-06-09
2014-03-31$115.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-09
$250.00K
derived: sum of 2 quarters · filed 2016-06-09
$273.00K
derived: sum of 3 quarters · filed 2016-06-09
$379.00K
10-K · filed 2016-06-09
$3.44M
10-K · filed 2014-06-10
2013-12-31$135.00K
10-Q · filed 2015-02-06
$158.00K
derived: sum of 2 quarters · filed 2015-02-06
$264.00K
10-Q · filed 2015-02-06
$479.00K
derived: sum of 4 quarters · filed 2015-06-09
$3.33M
10-Q · filed 2014-02-06
2013-09-30$23.00K
10-Q · filed 2014-11-07
$129.00K
10-Q · filed 2014-11-07
$344.00K
derived: sum of 3 quarters · filed 2015-06-09
$693.00K
derived: sum of 4 quarters · filed 2015-06-09
$3.19M
10-Q · filed 2013-11-08
2013-06-30$106.00K
10-Q · filed 2014-08-08
$321.00K
derived: sum of 2 quarters · filed 2015-06-09
$670.00K
derived: sum of 3 quarters · filed 2015-06-09
$1.14M
derived: sum of 4 quarters · filed 2015-06-09
$3.17M
10-Q · filed 2013-08-09
2013-03-31$215.00K
10-K · filed 2015-06-09
$564.00K
derived: sum of 2 quarters · filed 2015-06-09
$1.03M
derived: sum of 3 quarters · filed 2015-06-09
$1.29M
derived: sum of 4 quarters · filed 2015-06-09
$3.06M
10-KT · filed 2013-05-24
2012-12-31$349.00K
10-Q · filed 2014-02-06
$818.00K
derived: sum of 2 quarters · filed 2014-02-06
$1.08M
10-Q · filed 2014-02-06
$1.20M
10-K · filed 2015-06-09
$2.85M
10-K · filed 2013-03-15
2012-09-30$469.00K
10-Q · filed 2013-11-08
$469.24K
10-Q · filed 2012-11-14
$728.00K
10-Q · filed 2013-11-08
$848.21K
10-Q · filed 2012-11-14
$848.00K
derived: sum of 4 quarters · filed 2015-06-09
$2.50M
10-Q · filed 2012-11-14
2012-06-30$259.00K
10-Q · filed 2013-08-09
$258.98K
10-Q · filed 2012-08-14
$378.98K
10-Q · filed 2012-08-14
$379.00K
derived: sum of 3 quarters · filed 2015-06-09
$610.97K
derived: sum of 4 quarters · filed 2015-06-09
$2.03M
10-Q · filed 2012-08-14
2012-03-31$120.00K
10-K · filed 2015-06-09
$120.00K
derived: sum of 2 quarters · filed 2015-06-09
$351.97K
derived: sum of 3 quarters · filed 2015-06-09
$525.35K
derived: sum of 4 quarters · filed 2015-06-09
$1.77M
10-Q · filed 2012-05-15
2011-12-31$0.00
10-Q · filed 2012-01-17
$1.68K
10-Q · filed 2012-01-17
$405.35K
derived: sum of 3 quarters · filed 2012-11-14
$969.00K
10-K · filed 2014-06-10
$1.68K
10-Q · filed 2012-01-17
2011-09-30$231.97K
10-Q · filed 2012-11-14
$1.68K
10-Q · filed 2011-10-31
$405.35K
derived: sum of 2 quarters · filed 2012-11-14
$606.14K
10-Q · filed 2012-11-14
$606.14K
derived: sum of 4 quarters · filed 2012-11-14
$1.68K
10-Q · filed 2011-10-31
2011-06-30$173.38K
10-Q · filed 2012-08-14
$374.66K
10-Q · filed 2012-08-14
$374.16K
derived: sum of 3 quarters · filed 2012-08-14
$374.16K
derived: sum of 4 quarters · filed 2012-08-14
2011-03-31$200.79K
10-Q · filed 2012-05-15
$200.79K
derived: sum of 2 quarters · filed 2012-05-15
$200.79K
derived: sum of 3 quarters · filed 2012-05-15
2010-12-31$0.00
10-Q · filed 2012-01-17
$0.00
10-Q · filed 2012-01-17
$603.00K
10-KT · filed 2013-05-24
2010-09-30$0.00
10-Q · filed 2011-10-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
Silexion Therapeutics Corp (SLXN)$0.001B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70